This new TRIPS text from the WTO, it's generally the same as the earlier leaked text, but now with two brackets, one on the definition of eligible countries and the second one regarding requirement to list each patent in non-voluntary authorization.
At a Ways and Means Hearing, @LloydDoggettTX makes these comments to HHS Secretary Becerra, including a comment on the Xtandi march-in petition.
https://t.co/pxBiXbwNv7
@SecBecerra@WHO@MedsPatentPool "WHO, dozens of foreign countries and public health advocates have spent nearly two years urging the United States and other wealthy nations to share the technologies linked with their coronavirus vaccines, diagnostics and therapeutics." #CTAP@KEI_DC@Wemos@MedsLawPolicy
Senators Warren and King, and Representative Doggett ask HHS Secretary Becerra to move forward on Xtandi march in and government use rights, under existing Bayh-Dole safeguards
https://t.co/u8B4eoIiOU
Xtandi Bayh-Dole rights case: Memorandum in Support of Prostate Cancer Patient Petition Asking HHS to Use the US Government’s Rights in Patents to Enable Generic Competition
https://t.co/D9zMpjOOEL
STAT oped by Peter Arno, Robert Sachs and Kathryn Ardizzone: Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices.
https://t.co/jrIojGVFbc via @statnews
Biden Administration asked to clarify scope of sanctions exceptions for Cuba’s vaccine program, and to support the evaluation and registration of its COVID-19 vaccines
https://t.co/DfUy8oDJFJ